Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

CCHR Says Suspected Florida School Shooter Should Not Have Been in Reserve Officer Training if Taking Mind-Altering Stimulants

Defense Dept. disqualifies applicants on 'ADHD' drugs that cause aggression, abnormal thoughts, sudden outbursts & suicidal thoughts.


News provided by

Citizens Commission on Human Rights International

Feb 28, 2018, 02:30 ET

Share this article

Share toX

Share this article

Share toX

LOS ANGELES, Feb. 28, 2018 /PRNewswire/ -- The mental health watchdog, Citizens Commission on Human Rights (CCHR) today questioned how the recent suspected Florida school shooter was allowed to join the Douglas Army Junior Reserve Officer Training Corps (JROTC) when he had been prescribed drugs to treat "Attention Deficit Hyperactivity Disorder" (ADHD). Powerful stimulants such as methylphenidate are usually prescribed to treat ADHD, yet these can disqualify an applicant for joining ROTC generally and the Defense Forces.[1] ADHD stimulants such as methylphenidate are documented to cause hallucinations, behavior changes, aggression, abnormal thoughts, sudden outbursts, mood swings and thoughts of suicide.[2]

Continue Reading
Media reports that the alleged Florida school shooter was taking "ADHD medication" at least in 2013 and 2016 and it's unclear whether this continued and may have also been supplemented by psychotropic drugs prescribed for "depression."
Media reports that the alleged Florida school shooter was taking "ADHD medication" at least in 2013 and 2016 and it's unclear whether this continued and may have also been supplemented by psychotropic drugs prescribed for "depression."

Since 2014, the Department of Defense's medical qualification standards regarding these stimulants disqualifies applicants if they have been treated with ADHD drugs within the previous year and/or they displayed signs of ADD/ADHD. Even for applicants off the drugs for more than one year, if they are currently exhibiting "ADHD symptoms," a medical waiver is required.[3] In 2016, the alleged shooter was in the Junior ROTC where he excelled at shooting and marksmanship, using air rifles. Cadets called him the "wolf."[4] He was expelled for disciplinary issues in early 2017 and clearly before and during 2016, the shooter had displayed "impulse" issues. 

Media reports that the alleged shooter was taking "ADHD medication" at least in 2013 and 2016 and it's unclear whether this continued and may have also been supplemented by psychotropic drugs prescribed for "depression." When someone stops taking methylphenidate, within 24 hours, he can experience agitation and mood swings and within 14 days, anxiety, depression, sleep disorders and nervousness. A 2016 study published in JAMA Psychiatry also indicated that methylphenidate has a distinct effect on children that may lead to lasting neurological changes.[5] In another study published in Pediatrics in 2009, Andrew Mosholder, formerly from the Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, FDA, and others, concluded, "Patients and physicians should be aware that psychosis or mania arising during drug treatment of attention-deficit/hyperactivity disorder may represent adverse drug reactions."[6]

CCHR, which is compiling a comprehensive report on mass acts violence, found that in a random sample of 28 school-related acts of violence committed by those aged between 12 and 20, the drugs most frequently cited as taken by the perpetrators were the antidepressants fluoxetine (6); venlafaxine (3) and sertraline (2); "ADHD" drugs, including methylphenidate (6); and the sedative-hypnotics or benzodiazepines diazepam, and alprazolam (3).

A timeline on the alleged Florida school shooter's experience with the mental health system was also posted on CCHR International's website titled, "Florida School Shooter: Timeline on Mental Health System's Behavioral and Drug Treatment Failure to Prevent Senseless Violence." It includes information collected from media reports of the shooter being diagnosed or labeled and treated in the mental health system since the age of four.

This also points to a study where researchers took the Food and Drug Administration (FDA) Adverse Event Reporting System data and of 484 prescription drugs identified, 31 were found to be disproportionately associated with violence. These drugs, accounting for 79 percent of all the violence cases, included 25 psychotropic drugs.[7] The findings, published in Public Library of Science ONE, included 11 antidepressants, six sedative/hypnotics, and three ADHD drugs — supporting what it found in its random sample of school shootings. The specific cases of violence included: homicide, physical assaults, physical abuse, homicidal ideation, and cases described as a violence-related symptom.[8]

Among the drugs associated with the highest rates of violence compared to all drugs were six antidepressants that ranged from 7.9 times higher for sertraline, 8.3 times higher for venlafaxine to 10.9 times more likely for fluoxetine. Two stimulants ranged from 9.0 to 9.6 times more likely to be associated with violence than other prescription drugs.[9]

CCHR reiterated calls for federal and state investigations into the link between psychiatric drugs and violence — a call the group has made since the 1999 Columbine school shooting when a Colorado Ad Hoc government hearing was held into the issue. Then, Colorado State Representative Penn Pfiffner, who chaired the hearing, stated: "There is enough coincidence and enough professional opinion from legitimate scientists to cause us to raise the issue and to ask further questions." Further, "If we're only interested in debating gun laws and metal detectors, then we as legislators aren't doing our job."[10]

In 2006, Professor David Healy, a leading psychopharmacology expert and professor of psychiatry in Wales, was the lead author of a study which advised: "Legal systems are likely to continue to be faced with cases of violence associated with the use of psychotropic drugs, and it may fall to the courts to demand access to currently unavailable data. The problem is international and calls for an international response."[11]

Yet, states have failed to act, CCHR said. Yet, the behaviors being reported in the alleged Florida school shooter are not dissimilar to what was reported nearly 20 years ago. Columbine High School shooters, E. Harris and D. Klebold, had a troubled history like the suspected Florida shooter. They were arrested for burglarizing a car and court-ordered to "anger management" class.[12] As graduates of a Jefferson County "diversion program," Harris described his own "short temper, often get angry at almost anything I don't like, like people I have no respect for trying to tell me what to do." Harris also noted he experienced anger, anxiety, depression, disorganized thoughts, homicidal thoughts, jealousy, loneliness, mood swings, obsessive thoughts, racing thoughts, stress, suspiciousness and a temper.[13] Autopsy results revealed Harris had the antidepressant fluvoxamine in his system when he committed suicide.[14] There are many international drug regulatory warnings that link the antidepressant to suicidal behavior, hostility or aggression, agitation, abnormal behavior, mania or psychosis, self-harm, and violence.[15]

Unlike the alleged Florida school shooter who was able to join the ROTC, the Marine Corp rejected Harris when he applied to join after the recruiters found he was taking an antidepressant and seeing a psychiatrist. On a visit to Harris's home on April 15, 1999, Marine recruiters learned that he had taken the antidepressant, yet had explicitly stated on his application that he did not take any prescription drugs.[16] Five days later, the students staged their own private war at Columbine High School, killing 13 people before they finally killed themselves.

CCHR says that involuntary commitment of Harris, Klebold or the suspected Florida school shooter would not have prevented their murderous rampage and rejects any mental health industry demands for stronger commitment laws. They point to a young man (21), from Austin, Texas, who on May 1, 2017, stabbed four people with a machete-like hunting knife at the University of Texas, killing one and wounding three. The assailant had recently been involuntarily committed in another city and county records showed that he had been arrested and charged with Driving While Intoxicated on April 4, 2017. He was taking two "happy pills," which the arrest report listed as the antidepressant sertraline.[17]

"Unless states look at the potential for the 'treatment' to be a cause of or a contributing factor in violent behavior — especially with such a proliferation of school-aged children and adolescents prescribed psychotropic-psychiatric drugs — acts of violence in schools will likely escalate. The bottom line is psychiatric drugs create violence," Ms. Jan Eastgate, international president of CCHR, stated.

CCHR provided studies of violent adverse effects attributed to psychotropic drugs and testified before the Colorado State Board of Education following the Columbine High School shooting. On Nov. 11, 1999, the Board passed a Resolution that stated: "There are documented incidents of highly negative consequences in which psychiatric drugs have been utilized for what are essentially problems of discipline which may be related to a lack of academic success." The Board resolved to "encourage school personnel to use proven academic and/or classroom management solutions to resolve behavior, attention, and learning difficulties."[19]

CCHR says the Columbine resolution needs to be in place nationwide, with a zero tolerance to psychiatric drugs being forced onto school-aged children. Investigations are needed nationwide into the potential influence these drugs can have on behavior, acts of violence and suicide. 

CCHR is a mental health industry watchdog organization that has been investigating and collecting information on psychiatric drug links to school shooters and other acts of senseless violence since 1989 when a man shot dead eight people and injured 12 others at his workplace in Kentucky while taking the antidepressant fluoxetine. His medical records said the prescribing psychiatrist observed three days prior to the killing, an "increased level of agitation and anger."[19] CCHR has been responsible for more than 180 laws worldwide that now protect the rights of patients and families in the mental health system. As a nonprofit, CCHR relies on memberships and donations to carry out its mission and actions. Click here to support the cause.

Contact: Amber Rauscher, [email protected] or (323) 467-4242

References:

[1] https://www.thebalance.com/new-asthma-and-add-adhd-policy-3353970

[2] Ritalin, Side Effects Center, http://www.rxlist.com/ritalin-side-effects-drug-center.htm; Adderall, Side Effects Center, http://www.rxlist.com/adderall-side-effects-drug-center.htm.; https://www.cchrint.org/2017/04/05/study-shows-long-term-use-of-adhd-drugs-ineffective-as-treatment-but-do-cause-growth-suppression.

[3] https://www.thebalance.com/new-asthma-and-add-adhd-policy-3353970.

[4] https://www.inquisitr.com/4790263/nra-helped-nikolas-cruz-train-to-use-rifles-by-donating-10000-to-his-school-team/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+google%2FyDYq+%28The+Inquisitr+-+News%29&utm_content=Yahoo+Search+Results; http://www.dailymail.co.uk/news/article-5397023/Nikolas-Cruz-trained-taking-JROTC-marksmanship-course.html#ixzz57iNlnxBl.

[5] https://www.madinamerica.com/2016/08/study-finds-adhd-drugs-alter-developing-brain/ citing Anouk Schrantee et al, "Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity DisorderA Randomized Clinical Trial," JAMA Psychiatry, Sept. 2016;73(9):955-962.=, https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2538518.  

[6] Andrew D. Mosholder, MD, MPH, et al, "Hallucinations and Other Psychotic Symptoms Associated with the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children," Pediatrics, Vol. 123, No. 2, pp. 611-616, Feb. 2009.

[7] Thomas J. Moore, Joseph Glenmullen, Curt D. Furbert, "Prescription Drugs Associated with Reports of Violence Towards Others," Public Library of Science ONE, Vol. 5, Iss. 12, Dec. 2010, http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0015337

[8] Ibid.

[9] Ibid.

[10] Kelly P. O'Meara, "A Different Kind of Drug War," Insight Magazine, 13 Dec. 1999.

[11] David Healy,Andrew Herxheimer, and David B Menkes, "Antidepressants and Violence: Problems at the Interface of Medicine and Law," PLoS Medicine, Sept. 2006, 3(9): e372, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564177.

[12] https://www.denverpost.com/2006/07/06/columbine-documents-detail-troubled-lives.

[13] "Columbine Shooter's Clues Overlooked," Associated Press, 5 Nov. 2002; Carol Kreck, "Harris offered candid hints that 'something was wrong,'" Denver Post, 5 Nov. 2002.

[14] THE GOVERNOR'S COLUMBINE REVIEW COMMISSION, 2001,p. 18, https://schoolshooters.info/sites/default/files/Columbine%20-%20Governor%27s%20Commission%20Report.pdf.

[15] https://www.cchrint.org/psychiatric-drugs/antidepressantsideeffects/luvoxsideeffects.

[16] Joel Achenbach and Dale Russakoff, "Teen Shooter's Life Paints Antisocial Portrait," The Washington Post, 29 April 1999;"School gunman was seeing a psychiatrist," MSNBC, 28 April 1999.

[17] "One killed, three wounded in attack on University of Texas at Austin campus, police say," The Washington Post, 1 May, 2017, https://www.washingtonpost.com/news/grade-point/wp/2017/05/01/multiple-people-may-have-been-stabbed-on-university-of-texas-at-austin-campus-police-say/?utm_term=.1d1594a35677; "Affidavit: UT stabbing suspect says he doesn't remember attack," ABC13 News, 3 May 2017, http://abc13.com/news/affidavit-ut-stabbing-suspect-doesnt-remember-attack/1950054.

[18] Resolution, "Promoting the Use of Academic Solutions to Resolve Problems with Behavior, Attention, and Learning," Colorado State Board of Education, 1999.

[19] Transcript of the proceedings of the coroner's inquest into the Wesbecker murders, Jefferson County, 22 Nov. 1989, pp. I and 71-76.

Related Links

Florida School Shooter: Timeline on Mental Health System's Behavioral and Drug Treatment Failure to Prevent Senseless Violence

School Shootings: Mental Health Watchdog Says Psychotropic Drug Use by School Shooters Merits Federal Investigation

SOURCE Citizens Commission on Human Rights International

Related Links

http://www.cchrint.org

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.